➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

AstraZeneca
McKesson
Johnson and Johnson
McKinsey
Dow
Express Scripts

Last Updated: June 13, 2021

DrugPatentWatch Database Preview

Flibanserin - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for flibanserin and what is the scope of freedom to operate?

Flibanserin is the generic ingredient in one branded drug marketed by Sprout Pharms and is included in one NDA. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Flibanserin has eighty-two patent family members in thirty-one countries.

One supplier is listed for this compound.

Summary for flibanserin
International Patents:82
US Patents:4
Tradenames:1
Applicants:1
NDAs:1
Finished Product Suppliers / Packagers: 1
Raw Ingredient (Bulk) Api Vendors: 57
Clinical Trials: 19
Patent Applications: 939
Formulation / Manufacturing:see details
What excipients (inactive ingredients) are in flibanserin?flibanserin excipients list
DailyMed Link:flibanserin at DailyMed
Recent Clinical Trials for flibanserin

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Andrew McDonaldPhase 2
Sprout Pharmaceuticals, IncPhase 2
Mohit KheraPhase 2

See all flibanserin clinical trials

Pharmacology for flibanserin
Mechanism of ActionP-Glycoprotein Inhibitors

US Patents and Regulatory Information for flibanserin

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sprout Pharms ADDYI flibanserin TABLET;ORAL 022526-001 Aug 18, 2015 RX Yes Yes   Get Started Free   Get Started Free   Get Started Free
Sprout Pharms ADDYI flibanserin TABLET;ORAL 022526-001 Aug 18, 2015 RX Yes Yes   Get Started Free   Get Started Free   Get Started Free
Sprout Pharms ADDYI flibanserin TABLET;ORAL 022526-001 Aug 18, 2015 RX Yes Yes   Get Started Free   Get Started Free Y Y   Get Started Free
Sprout Pharms ADDYI flibanserin TABLET;ORAL 022526-001 Aug 18, 2015 RX Yes Yes   Get Started Free   Get Started Free   Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Mallinckrodt
McKesson
Colorcon
Moodys
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.